US
Udit Sanjay Ruia
About Udit Sanjay Ruia
Data last updated:
Udit Sanjay Ruia is a Director at Shree Flex Print Private Limited (since 2024), Director at Genome Pharmaceuticals And Chemicals Private Limited (since 2024) and Designated Partner at Shri Yantra Medicare Llp (since 2025). The companies operate in Packaging and Chemicals and Materials. The 2 current companies with reported revenue have a combined latest revenue of ₹22.19 Cr; the largest is Shree Flex Print Private Limited at ₹21.96 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 10 Oct 2024 | 1998 | ₹21.96 Cr (FY 2025) | Active | |
| Director | 20 Sep 2024 | 1994 | ₹23.5 Lakh (FY 2025) | Active | |
| Designated Partner | 12 Sep 2025 | 2025 | Active |
Board colleagues of Udit Sanjay Ruia
| Name | DIN | Company | Designation |
|---|---|---|---|
| Mohit Ratankumar Kedia | 07025468 | Shree Flex Print Private Limited | Director |
| Radheshyam Govindlal Kedia | 00393491 | Shree Flex Print Private Limited | Director |
| Saurav Agarwal | 06704014 | Shree Flex Print Private Limited | Director |
| Ramanathan Sivaramakrishnan Iyer | 07149080 | Genome Pharmaceuticals And Chemicals Private Limited | Director |
| Sanjay Govind Prasad Ruia | 02251066 | Genome Pharmaceuticals And Chemicals Private Limited , Shri Yantra Medicare Llp | Director |
| Ritika Madhusudan Ruia | 01409189 | Shri Yantra Medicare Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Udit Sanjay Ruia
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Udit Sanjay Ruia
Udit Sanjay Ruia currently holds 3 directorships: Shree Flex Print Private Limited (Director, since 10 Oct 2024, revenue ₹21.96 Cr (FY 2025)); Genome Pharmaceuticals And Chemicals Private Limited (Director, since 20 Sep 2024, revenue ₹23.5 Lakh (FY 2025)); Shri Yantra Medicare Llp (Designated Partner, since 12 Sep 2025).
Udit Sanjay Ruia was first appointed on 20 Sep 2024 as Director at Genome Pharmaceuticals And Chemicals Private Limited. The most recent appointment on record is 12 Sep 2025 at Shri Yantra Medicare Llp.
The 2 current companies of Udit Sanjay Ruia that report revenue have a combined latest revenue of ₹22.19 Cr: Shree Flex Print Private Limited ₹21.96 Cr (FY 2025); Genome Pharmaceuticals And Chemicals Private Limited ₹23.5 Lakh (FY 2025).
The current boards of Udit Sanjay Ruia's companies include Mohit Ratankumar Kedia (Shree Flex Print Private Limited), Radheshyam Govindlal Kedia (Shree Flex Print Private Limited), Saurav Agarwal (Shree Flex Print Private Limited), Ramanathan Sivaramakrishnan Iyer (Genome Pharmaceuticals And Chemicals Private Limited), Sanjay Govind Prasad Ruia (Genome Pharmaceuticals And Chemicals Private Limited), Ritika Madhusudan Ruia (Shri Yantra Medicare Llp).